| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |